188
Participants
Start Date
November 1, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Liraglutide + Metformin
Metformin XR (extended-release) was initiated at 750 mg once daily and increased to 1500 mg once daily after 2 week. Concomitantly, Liraglutide was initiated at a subcutaneous dose of 0.6 mg once daily for 1 week, then titrated in increments of 0.6 mg once daily every 1 to 3 weeks to a maintenance dose of 3.0 mg once daily for up to 12 weeks
Metformin
Metformin XR (extended-release) was initiated at 750 mg once daily and increased to 1500 mg once daily after 2 week
Mỹ Đức Hospital
OTHER